Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Study limitation reported by the research below: “The 'practice changing' impact flag is applied tentatively — this is a phase 2b signal; phase 3 confirmation is pending.”